http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2771233-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f220ff41ebe4c7f2e7da8ec7e7e9dca |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d597576bc6ffaf44f0ed8b1bc0d8e61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa75fea28a5411ea9cba46fc0286f699 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e951069503a5eac134a9c2a394dbd074 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a826a63fb341c923a8594490e40401d |
| publicationDate | 2022-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2771233-C1 |
| titleOfInvention | Method for implantation of ahmed antiglaucoma valve |
| abstract | FIELD: medicine; ophthalmology. n SUBSTANCE: invention relates to medicine, namely to ophthalmology; it can be used to prevent scarring of the tenon capsule during implantation of the Ahmed antiglaucoma valve. To do this, an incision of the conjunctiva in the upper temporal segment is performed along the limb from 12 to 8 hours in the downward direction with the outcrop of the upper temporal segment of the sclera for the right eye and from 12 to 4 hours for the left eye with the extension of the incision perpendicular to the tangent to the limb 4 mm from it. The valve is activated with a saline solution. Next, viscoelastic is injected into it through a tube. A valve body is implanted into the formed pocket in the subtenant space, fixed with sutures to the sclera through fixing holes. Then, a triangular scleral flap is formed with a base to the limb on the thickness of the sclera, 4 mm long perpendicular to the tangent to the limb and 3 mm parallel to the tangent to the limb. 23 G needle is inserted under this flap 2 mm from the limb parallel to the iris, forming a scleral tunnel into the anterior chamber. The valve tube is cut at an angle of 30 degrees. Then, the valve tube is inserted through the formed tunnel, then, the scleral flap is sutured with three nodular sutures, after which 0.1 ml of HealaFlow drainage implant is injected from each side of the valve body, edges of the conjunctiva are matched and fixed with a continuous suture at 8 hours for the right eye and at 4 hours for the left eye. n EFFECT: invention provides stabilization of intraocular pressure, prevention of early postoperative hypotension, ciliochoroidal detachment, as well as prevention of scarring of the tenon capsule in the postoperative period. n 1 cl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2787150-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2789427-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2796952-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2786144-C1 |
| priorityDate | 2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.